Enanta Pharmaceuticals reported $207K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US USD 32.37B 1.03B
Anika Therapeutics ANIK:US USD 146K 0
Arrowhead Research ARWR:US USD 198K 0
AstraZeneca AZN:LN USD 387M 0
Biogen BIIB:US USD 100K 0
Bristol Myers Squibb BMY:US USD 292M 0
Clovis Oncology CLVS:US USD 145K 1000
GlaxoSmithKline GSK:LN GBP 1.35B 0
Halozyme Therapeutics HALO:US USD 135K 3K
Heron Therapeutics HRTX:US USD 1.19M 163K
Insmed INSM:US USD 1.22M 18K
Intercept Pharmaceuticals ICPT:US USD 41K 11K
IONIS PHARMACEUT IONS:US USD 142K 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Marinus Pharmaceuticals MRNS:US USD 37K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 878.25M 11.75M
Novavax NVAX:US USD 792K 4K
Ptc Therapeutics PTCT:US USD 71K 0
Roche Holding ROG:VX 107M 53M
Sarepta Therapeutics SRPT:US USD 9K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Vital Therapies VTL:US USD 3K 0
YTE INCY:US USD 222K 0